Paper36367262
Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
Pereira-Souza AL and 5 others. J Refract Surg, 2022. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience. Papers, record 36367262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36367262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Keratomileusis, Laser In Situ | Major topic |
| Corneal Diseases | Major topic |
| Corneal Opacity | Major topic |
| Female | |
| Humans | |
| Adult | |
| Losartan | |
| Visual Acuity | |
| Vision Disorders | |
| Fibrosis | |
| Corneal Stroma | |
| Lasers, Excimer |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07449000 | Losartan for Corneal Fibrosis | Background |
Source ClinicalTrials.gov
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923547 | Topical Losartan in the Management of Corneal Scarring from Trauma and Infection: A Case Series. | Case Rep Ophthalmol | 2026 | https://conductscience.org/library/papers/42923547 | PubMed |
| 42346035 | The Role of Epigenetics in Corneal Fibrosis. | Epigenomes | 2026 | https://conductscience.org/library/papers/42346035 | PubMed |
| 41778091 | Topical losartan to prevent stromal scarring during post-cross-linking infection in pediatric keratoconus: A case report. | Am J Ophthalmol Case Rep | 2026 | https://conductscience.org/library/papers/41778091 | PubMed |
| 41753041 | Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications. | J Clin Med | 2026 | https://conductscience.org/library/papers/41753041 | PubMed |
| 41594872 | Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41594872 | PubMed |
| 41573013 | Fungal keratitis following laser assisted lenticule extraction surgery with use of losartan as an anti-scarring agent - a case report. | Am J Ophthalmol Case Rep | 2026 | https://conductscience.org/library/papers/41573013 | PubMed |
| 41339873 | Vision rehabilitation of post-Descemet membrane endothelial keratoplasty Pseudomonas keratitis utilizing losartan ophthalmic solution and scleral contact lens: a case report. | J Med Case Rep | 2025 | https://conductscience.org/library/papers/41339873 | PubMed |
| 41245430 | Topical losartan for established corneal fibrosis with machine learning-based predictors. | Ther Adv Ophthalmol | 2025 | https://conductscience.org/library/papers/41245430 | PubMed |
| 41146269 | Effect of enalapril and losartan on the expression of genes involved in inflammation, fibrogenesis, and apoptosis in orbital fibroblasts of graves' ophthalmopathy. | BMC Res Notes | 2025 | https://conductscience.org/library/papers/41146269 | PubMed |
| 40745008 | Protecting kidney function: from mechanisms to therapeutic targets and traditional Chinese medicine. | Ren Fail | 2025 | https://conductscience.org/library/papers/40745008 | PubMed |
| 40530230 | The Potential Role of Topical Losartan in Reducing Subepithelial Haze in Traumatic Laser-Assisted In Situ Keratomileusis (LASIK) Flap Avulsion. | Cureus | 2025 | https://conductscience.org/library/papers/40530230 | PubMed |
| 40248823 | Topical Losartan Treatment of Herpes Simplex Virus- or Varicella-Zoster Virus-Induced Corneal Scarring: A Case Series. | Case Rep Ophthalmol | 2025 | https://conductscience.org/library/papers/40248823 | PubMed |
| 40103911 | Effect of 0.8mg/ml Losartan on Corneal Opacities. | Pak J Med Sci | 2025 | https://conductscience.org/library/papers/40103911 | PubMed |
| 39665995 | Topical losartan ophthalmic drops - a review of corneal wound healing and topical losartan for managing corneal haze and potential future indications. | Graefes Arch Clin Exp Ophthalmol | 2025 | https://conductscience.org/library/papers/39665995 | PubMed |
| 39133495 | Effect of Topical Losartan in the Treatment of Established Corneal Fibrosis in Rabbits. | Transl Vis Sci Technol | 2024 | https://conductscience.org/library/papers/39133495 | PubMed |
| 38791518 | Available Therapeutic Options for Corneal Neovascularization: A Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791518 | PubMed |
| 38540264 | Regenerative Therapy for Corneal Scarring Disorders. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540264 | PubMed |
| 37934291 | Classic lattice corneal dystrophy: a brief review and summary of treatment modalities. | Graefes Arch Clin Exp Ophthalmol | 2024 | https://conductscience.org/library/papers/37934291 | PubMed |
| 37750746 | Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits. | Transl Vis Sci Technol | 2023 | https://conductscience.org/library/papers/37750746 | PubMed |
| 37603162 | Management of Corneal Haze After Photorefractive Keratectomy. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/37603162 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36367262
GET https://conductscience.org/api/papers/v1/36367262/cited_by?page=2